Tatva Chintan Pharma Chem shares decline 9% after EBITDA falls 6% YoY in December 2021
Shares of Tatva Chintan Pharma Chemical Ltd tanked as much as 9 per cent in the early trade on the BSE on Tuesday, a day after recently listed specialty chemical firm posted Q3Fy22 results on Monday
Tatva Chintan Pharma Chem had debuted on the stock market last year at a huge premium as the shares of the company got listed at Rs 2,111.80 on BSE, a 95 per cent premium over its issue price of Rs 1,083.